icon icon
icon
icon
Ask
icon
icon

XORTX Therapeutics

XRTX

XRTX XORTX Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    XRTX Chart
    See on advanced chart >

    About

    XORTX Therapeutics Inc. was incorporated under the laws of Alberta, Canada on August 24, 2012, under the name ReVasCor Inc. On January 10, 2018,changed the company name to “XORTX Therapeutics Inc.” The company is a clinical-stage biotechnology company focused...
    Read More
    • Highlight
      A clinical-stage biotechnology company focused on therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in renal indications
      • Industry
      Pharmaceuticals
    • Exchange
      NASDAQ
    • Listing Date
      10/13/2021
    • Established Date
      08/24/2012
    • Full-time Employees
      2
    • Address
      3710—33rd Street NW Calgary Alberta T2L 2M1 Canada
    • Tel
      1-403-4557727
    • Website
      www.xortx.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock